Publication | Closed Access

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

Retrospective Consortium AnalysisMedicinePathologyColorectal CancerPik3ca MutationsCancer TreatmentOncologyRadiation Oncology